Cryotherapy Following Rotator Cuff Repair Surgery
Rotator Cuff Tears
About this trial
This is an interventional supportive care trial for Rotator Cuff Tears focused on measuring Arthroscopy, Opioid Use
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing primary arthroscopic rotator cuff repair.
Exclusion Criteria:
- Patients with any of the following pre-existing medical conditions: Fibromyalgia; Complex regional pain syndrome; Any pain disorder that requires the patient to take narcotic pain medication in the pre-operative time period
- Patients undergoing revision arthroscopic rotator cuff surgery
- Illiterate, non-English speaking, and pregnant individuals
Sites / Locations
- University Hospitals Cleveland Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Breg Polarcare
Thermazone
Patients within the Breg Polarcare treatment arm will use the Breg Polarcare device for the first two days post-operatively following their arthroscopic rotator cuff repair. They will switch to the Thermazone device for post-operative days 3 and 4. They will continue to alternate every two days for 8 days total post-operatively.
Patients within the Thermazone treatment arm will use the Thermazone device for the first two days post-operatively following their arthroscopic rotator cuff repair. They will switch to the Breg Polarcare device for post-operative days 3 and 4. They will continue to alternate every two days for 8 days total post-operatively.